LEXARIA BIOSCIENCE CORP. Payments for (Proceeds from) Investments
LEXARIA BIOSCIENCE CORP. (LEXX) reported Payments for (Proceeds from) Investments of $0 for the 12-month period ending 2015-08-31, per its 10-K filed 2015-11-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsForProceedsFromInvestments · last filed 2015-11-27
- LEXARIA BIOSCIENCE CORP. payments for (proceeds from) investments for the quarter ending 2013-10-31 was $0.00.
- LEXARIA BIOSCIENCE CORP. payments for (proceeds from) investments for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- LEXARIA BIOSCIENCE CORP. payments for (proceeds from) investments for fiscal 2014 was $7.66K.
- LEXARIA BIOSCIENCE CORP. payments for (proceeds from) investments for fiscal 2013 was $0.00.
| Period end | Payments for (Proceeds from) Investments 3 month | Payments for (Proceeds from) Investments 9 month | Payments for (Proceeds from) Investments 10 month | Payments for (Proceeds from) Investments 12 month |
|---|---|---|---|---|
| 2015-08-31 | $0.00 10-K · filed 2015-11-27 | |||
| 2014-08-31 | $7.66K 10-KT · filed 2014-12-09 | $7.66K 10-K · filed 2015-11-27 | ||
| 2014-07-31 | $51.56K 10-Q · filed 2014-11-14 | |||
| 2013-10-31 | $0.00 derived: 10-KT 12 month − 10-Q 9 month · filed 2014-12-09 | $0.00 10-KT · filed 2014-12-09 | ||
| 2013-08-31 | $0.00 10-KT · filed 2014-12-09 | |||
| 2013-07-31 | $0.00 10-Q · filed 2014-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |